L. Bergendal et al., POTENTIAL DRUG-DRUG INTERACTIONS IN 5,125 MOSTLY ELDERLY OUT-PATIENTSIN GOTHENBURG, SWEDEN, Pharmacy world & science, 17(5), 1995, pp. 152-157
Of 5,125 mostly elderly out-patients, average age 78.2 years, 1,594 (3
1%) had at least one interacting drug combination according to the Swe
dish National Formulary. On average, each patient with drug-drug inter
actions (DDIs) had 1.6 DDIs. There was no difference in the sex or age
between those having DDIs and those without. However, patients with o
ne or more DDIs used a significantly larger number of drugs than those
without DDIs, on average 8.1 versus 5.2. This significant difference
was independent of age and sex. When classified for clinical significa
nce according to the handbook ''Drug Interactions and Updates'' by Han
sten and Horn, 155 (3%) patients had interactions of 'major clinical s
ignificance'. The most common were interactions between beta-adrenergi
c blockers and antidiabetics, followed by potassium-sparing diuretics
and potassium, and carbamazepine and dextropropoxyphene. The methodolo
gy allows us to screen routinely for DDIs and to plan further studies
with emphasis on clinical outcome.